Share price
₹472.8 latest close · +118.4% over the last 90 sessions
₹472.8 month-end · +212.6% over 12 months
₹472.8 month-end · +439.1% over 3 years
₹472.8 month-end · +3454.9% since Mar '20
52-week range ₹94.77 to ₹479.95 · 1-year volatility 49.7%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-68.1% (2020-12 peak to 2025-02 low, recovered 2026-07)
-36.9% (2020-11 peak to 2020-12 low, recovered 2020-12)
-16.6% (2026-08 peak to 2026-08 low, recovered 2026-08)
Most recent volume spikes
2026-09-01: 5.2x the 50-day median, price +2.7% that day
2026-08-31: 5.4x the 50-day median, price +4.5% that day
2026-08-06: 111.2x the 50-day median, price +2.0% that day
Beta is the slope of daily returns against a market-cap-weighted index of the sector's other listed companies, built from today's constituents (so it excludes companies no longer listed).
Where does it rank among Health Technology peers?
Each cell is the company's percentile rank among its Health Technology peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE7thflat vs a year ago
- Revenue growth18th▼ 7 pts vs a year ago
- Debt/equity ↓74thflat vs a year ago
- Cash cycle ↓91stflat vs a year ago
- 12M momentum98thflat vs a year ago
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Technology sector page Watch it move against Health Technology in the Observatory
What is the price implying?
Trailing earnings per share are negative, so a P/E-based figure does not exist. See the loss-makers list on the Expectations Gap page for a revenue-based version.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Technology The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹472.80
- ROCE
- -3.0%
- Market Cap
- ₹1099 cr
- Revenue (TTM)
- ₹42 cr
- P/S
- 26.2x
- P/B
- 21.5x
- ROE
- -476.4%
- Debt / Equity
- 0.1x
- Promoter Holding
- 75.0%
- 12M Momentum
- 212.6%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance—Not enough data
Not enough reported data to compute this.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion—Not enough data
Not enough reported data to compute this.
Free cash flow2 of 5 yrsNear threshold
Fiscal years with positive free cash flow in the last 5: 2. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history0 daysWithin range
Debtor days are below the median of the previous three fiscal years by 0 days (52 vs 52). Bands: under 15 days, 15 to 45, over 45.
Capital work in progress0% of fixed assetsWithin range
Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days0 days / 2 yrsWithin range
Days payable changed by 0 over two years. Bands: rise of up to 30 days; more than 30 days.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
Who has been buying and selling?
- Over 3 years, promoters trimmed 13.7 pts; FIIs added 9.3 pts.
Holdings, Jun '26
How each group changed
Number of shareholders
Quarterly shareholding as reported, labelled by the quarter it covers (it becomes visible about two months later).
Shareholder counts are only available for recent quarters.
What happened next to similar setups
- We found 50 past situations where a non-financial company looked like BAFNA PHARMACEUTICALS LIMITED today on valuation, return on capital, debt, growth, price momentum, size and volatility.
- Over the following 12 months the middle half of them returned −46% to +2% vs the market, against −5% for all non-financial companies in the same months.
- The analogs' median sat below that base rate (gap −19.0%, 80% range −29.2% to −15.2%), but the matches cluster in only 5 distinct 12-month windows.
Where the 50 outcomes landed
Each dot is one past situation (hover or tap for details) · Solid dots are the closest matches, listed below · Shaded is the middle half of all companies in the same months · 1 beyond the range shown, drawn at the edge
50 past situations · 50 companies · 33 months · 2020–2025
The closest matches
| Company | When | P/E | ROCE | 12M mom. | Drawdown | Next 12 months |
|---|---|---|---|---|---|---|
| GENESYS Technology Services |
Feb 2022 | — | -7% | +506% | −1% | −20% |
| RSSOFTWARE Technology Services |
Feb 2024 | — | -24% | +578% | 0% | −60% |
| MODIRUBBER Consumer Durables |
Feb 2021 | — | 0% | +476% | 0% | −63% |
| WINDMACHIN Producer Manufacturing |
Jun 2025 | 308x | 1% | +170% | −7% | −24% |
| ARROWGREEN Process Industries |
May 2023 | — | -12% | +287% | 0% | +8% |
Show the other 3 matches
How reliable is this?
Matched on P/S, ROCE, debt/equity, revenue growth, 12-month momentum, drawdown from 12-month high, size and volatility. Closest on: ROCE, volatility and size. Not used (unavailable for this company): P/E, operating margin and interest cover. This company is loss-making, so it was only compared with loss-making companies. One match per company and at most 7 from any one month.
Independent periods: the matches fall in 5 distinct 12-month windows. Matches from nearby months share the same market conditions, so fewer windows means less evidence.
What else looks like this?
Companies with the most similar financial profile today, regardless of industry.
Similarity is statistical, based on reported metrics; it does not imply similar business quality or future returns.
What changed?
28 events since Jun '20
- AugPriceVolume reached 111.2x its 50-day median on 2026-08-06; price +2.0% that day.
- JulPriceRegained the 2020-12 peak, 17 months after the low.
- JunPriceVolume reached 99.2x its 50-day median on 2026-06-09; price -10.0% that day.
- MarPriceVolume reached 6.5x its 50-day median on 2026-03-27; price -3.1% that day.
- DecPriceVolume reached 10.0x its 50-day median on 2025-12-24; price +4.3% that day.
- AugPriceVolume reached 22.4x its 50-day median on 2025-08-18; price +5.0% that day.
- JunPromoterPromoter holding fell 13.3 pts to 75.0%.
- AprPriceVolume reached 11.4x its 50-day median on 2025-04-25; price +4.5% that day.
Show 20 earlier events
- FebPriceFell 68% from the Dec 2020 peak to the Feb 2025 low.
- JanPriceVolume reached 17.2x its 50-day median on 2025-01-08; price +1.1% that day.
- OctPriceVolume reached 5.3x its 50-day median on 2024-10-01; price -1.5% that day.
- SepPriceVolume reached 16.0x its 50-day median on 2024-09-23; price +5.0% that day.
- MayPriceVolume reached 12.1x its 50-day median on 2024-05-06; price +5.0% that day.
- MarPriceVolume reached 8.8x its 50-day median on 2024-03-27; price -0.1% that day.
- NovPriceVolume reached 21.8x its 50-day median on 2023-11-28; price +0.6% that day.
- AugPriceVolume reached 17.5x its 50-day median on 2023-08-11; price +5.0% that day.
- SepPriceVolume reached 15.7x its 50-day median on 2022-09-02; price +0.4% that day.
- JunPriceVolume reached 8.5x its 50-day median on 2022-06-02; price +5.0% that day.
- FebPriceVolume reached 53.4x its 50-day median on 2022-02-23; price +0.5% that day.
- DecPriceVolume reached 14.0x its 50-day median on 2021-12-31; price +10.0% that day.
- JulPriceVolume reached 15.7x its 50-day median on 2021-07-19; price +10.0% that day.
- MayPriceVolume reached 14.7x its 50-day median on 2021-05-07; price +0.1% that day.
- MarDebtDebt / equity halved over 12 months to 0.06x.
- MarPriceVolume reached 14.8x its 50-day median on 2021-03-16; price +5.0% that day.
- DecPriceRegained the 2020-11 peak, 0 months after the low.
- DecPriceFell 37% from the Nov 2020 peak to the Dec 2020 low.
- OctPriceVolume reached 66.5x its 50-day median on 2020-10-08; price +4.9% that day.
- JunDebtDebt / equity fell below 1.0x (0.06x).
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history81 months · 2020-03 to 2026-11
| Month | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|
| 2026-11 | ₹42 cr | -476.4% | -3.0% | 0.1x |
| 2026-10 | ₹42 cr | -476.4% | -3.0% | 0.1x |
| 2026-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2026-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2025-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2024-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2023-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2022-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-05 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-04 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-03 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-02 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2021-01 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-12 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-11 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-10 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-09 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-08 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-07 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-06 | ₹42 cr | -47.1% | -3.0% | 0.1x |
| 2020-05 | ₹44 cr | -94.7% | -22.0% | 2.4x |
| 2020-04 | ₹44 cr | -94.7% | -22.0% | 2.4x |
| 2020-03 | ₹44 cr | -94.7% | -22.0% | 2.4x |